U.K. Study: Alcohol Use Tied to Less Disability in Chronic Pain

This article originally appeared here.
Share this content:
U.K. Study: Alcohol Use Tied to Less Disability in Chronic Pain
U.K. Study: Alcohol Use Tied to Less Disability in Chronic Pain

FRIDAY, July 31, 2015 (HealthDay News) -- Moderate to heavy drinking might cut the likelihood of disability for people with chronic widespread pain such as that related to fibromyalgia, according to new research published online July 20 in Arthritis Care & Research.

Gary Macfarlane, M.D., Ph.D., and Marcus Beasley of the University of Aberdeen's Institute of Applied Health Sciences School of Medicine and Dentistry in the United Kingdom surveyed 13,574 U.K. adults (57 percent women), 2,239 of whom reported chronic widespread pain. They found that disability stemming from pain was strongly linked to alcohol consumption, with moderate to heavy drinkers experiencing less disability.

The researchers found that people drinking 21 to 35 units of alcohol a week were 67 percent less likely than those who never drink to experience disability. Those amounts translate roughly into 15 to 20 beers or 10 to 15 glasses of wine per week by American standards, constituting moderate to heavy drinking.

The authors could not be reached for comment, but in the study they note that a significant number of participants were drinking more than the recommended limit. Alan Manevitz, M.D., a clinical psychiatrist at Lenox Hill Hospital in New York City, told HealthDay that he agreed with the study authors that the findings should not be interpreted to mean that alcohol has a therapeutic benefit for pain. "It's a poor self-medication and it ultimately causes further deterioration in patients with pain," he said.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »